This is thought to represent indirect effects (mediated by reductions in insulin resistance) and possible direct effects (via surgically induced changes in GIP, GLP-1, and affiliated peptide hormones) on the ovaries and the hypothalamic–pituitary–adrenal axis. The gene discussed is GCG; the disease is Insulin resistance.